7-methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 inhibitors:: A potential treatment for asthma

被引：20

作者：

Buckley, GM ^{[1
]}

Cooper, N ^{[1
]}

Davenport, RJ ^{[1
]}

Dyke, HJ ^{[1
]}

Galleway, FP ^{[1
]}

Gowers, L ^{[1
]}

Haughan, AF ^{[1
]}

Kendall, HJ ^{[1
]}

Lowe, C ^{[1
]}

Montana, JG ^{[1
]}

Oxford, J ^{[1
]}

Peake, JC ^{[1
]}

Picken, CL ^{[1
]}

Richard, MD ^{[1
]}

Sabin, V ^{[1
]}

Sharpe, A ^{[1
]}

Warneck, JBH ^{[1
]}

机构：

[1] Celltech R&D, Cambridge CB1 6GS, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 03期

关键词：

D O I：

10.1016/S0960-894X(01)00786-7

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis and pharmacological profile of a novel series of 7-methoxy-furo[2,3-c]pyridine-4-carboxamides is described. Some of these compounds were found to be potent inhibitors of phosphodiesterase type 4 (PDE4). Initial (C) 2002 Elsevier Science Ltd. All rights reserved.

引用

页码：509 / 512

页数：4

共 18 条

[1] 7-methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: A potential treatment for asthma
Buckley, G
Cooper, N
Dyke, HJ
Galleway, F
Gowers, L
Gregory, JC
Hannah, DR
Haughan, AF
Hellewell, PG
Kendall, HJ
Lowe, C
Maxey, R
Montana, JG
Naylor, R
Picken, CL
Runcie, KA
Sabin, V
Tuladhar, BR
Warneck, JBH
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (18) : 2137 - 2140
[2] CAVALLA D, 1995, CURR MED CHEM, V2, P561
[3] DEMOLIOUMASON CD, 1995, EXPERT OPIN THER PAT, V5, P417
[4] Biarylcarboxylic acids and -amides: Inhibition of phosphodiesterase type IV versus [H-3]rolipram binding activity and their relationship to emetic behavior in the ferret
Duplantier, AJ
Biggers, MS
Chambers, RJ
Cheng, JB
Cooper, K
Damon, DB
Eggler, JF
Kraus, KG
Marfat, A
Masamune, H
Pillar, JS
Shirley, JT
Umland, JP
Watson, JW
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) : 120 - 125
[5] Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease
Giembycz, MA
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (07) : 1361 - 1379
[6] Jacobitz S, 1996, MOL PHARMACOL, V50, P891
[7] Phosphodiesterase 4 in macrophages: Relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [H-3]R-(-)-rolipram binding by selective inhibitors
Kelly, JJ
Barnes, PJ
Giembycz, MA
[J]. BIOCHEMICAL JOURNAL, 1996, 318 : 425 - 436
[8] INHIBITORY EFFECT OF THE TRFK-5 ANTI-IL-5 ANTIBODY IN A GUINEA-PIG MODEL OF ASTHMA
MAUSER, PJ
PITMAN, A
WITT, A
FERNANDEZ, X
ZURCHER, J
KUNG, T
JONES, H
WATNICK, AS
EGAN, RW
KREUTNER, W
ADAMS, GK
[J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (06): : 1623 - 1627
[9] EFFECTS OF AN ANTIBODY TO INTERLEUKIN-5 IN A MONKEY MODEL OF ASTHMA
MAUSER, PJ
PITMAN, AM
FERNANDEZ, X
FORAN, SK
ADAMS, GK
KREUTNER, W
EGAN, RW
CHAPMAN, RW
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (02) : 467 - 472
[10] Benzofuran based PDE4 inhibitors
McGarry, DG
Regan, JR
Volz, FA
Hulme, C
Moriarty, KJ
Djuric, SW
Souness, JE
Miller, BE
Travis, JJ
Sweeney, DM
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (06) : 1131 - 1139

← 1 2 →